Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Maria Rosaria Diadema
Neutrophil to Lymphocyte Ratio (NLR) for Prediction of Distant Metastasis-Free Survival (DMFS) in Early Breast Cancer: A Propensity Score-Matched Analysis
ESMO Open
Cancer Research
Oncology
Related publications
Prognostic Role for Derived Neutrophil-To-Lymphocyte Ratio in Early Breast Cancer
Annals of Oncology
Medicine
Oncology
Hematology
Changes in Neutrophil-To-Lymphocyte Ratio (NLR) During Chemoradiation for Head and Neck Cancer Are Significant Predictor for Overall Survival
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Pretreatment Neutrophil-To-Lymphocyte Ratio (NLR) and Platelet-To-Lymphocyte Ratio (PLR) as a Predictive Value of Hematological Markers in Cervical Cancer
Asian Pacific Journal of Cancer Prevention
Letter: There's Something About the Neutrophil-To-Lymphocyte Ratio (NLR)…
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Evaluation of the Early Prognostic Value of Neutrophil-Lymphocyte Ratio (Nlr) and Platelet-Lymphocyte Ratio (Plr) in Snakebite Poisoned Patients
The Egyptian Journal of Forensic Sciences and Applied Toxicology
Baseline Neutrophil-To-Lymphocyte Ratio (NLR) and Derived NLR Could Predict Overall Survival in Patients With Advanced Melanoma Treated With Nivolumab
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Prognostic Value of Neutrophil‐to‐lymphocyte Ratio and Platelet‐to‐lymphocyte Ratio for Breast Cancer Patients: An Updated Meta‐analysis of 17079 Individuals
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Neutrophil–lymphocyte Ratio Predicts Response to Chemotherapy in Triple-Negative Breast Cancer
Current Oncology
Oncology
Prognostic Significance of Neutrophil-To-Lymphocyte Ratio in Rectal Cancer: A Meta-Analysis
OncoTargets and Therapy
Oncology
Pharmacology
